Arne Forsgren v Österreichisches Patentamt.

Core Citations

WORK EXPRESSION OF in

• Arne Forsgren v Österreichisches Patentamt.

This document cites

• Glaxosmithkline Biologicals SA and Glaxosmithkline Biologicals, Niederlassung der Smithkline Beecham Pharma GmbH & Co. KG v Comptroller General of Patents, Designs and Trade Marks.
• Georgetown University and Others v Comptroller General of Patents, Designs and Trade Marks.
• Medeva BV v Comptroller General of Patents, Designs and Trade Marks.
• Novartis AG v Actavis Deutschland GmbH & Co. KG and Actavis Ltd.
• Bayer CropScience AG v Deutsches Patent- und Markenamt.



See all quotations

• Novartis AG v Actavis UK Ltd.
• Eli Lilly and Company Ltd v Human Genome Sciences Inc.
• Massachusetts Institute of Technology.
• Directive 2001/38/EC of the European Parliament and of the Council of 5 June 2001 amending Council Directive 93/7/EEC on the return of cultural objects unlawfully removed from the territory of a Member State (Text with EEA relevance)
• Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use
• Regulation (EC) No 469/2009 of the European Parliament and of the Council of 6 May 2009 concerning the supplementary protection certificate for medicinal products (Codified version) (Text with EEA relevance)
• Regulation (EC) No 726/2004 of the European Parliament and of the Council of 31 March 2004 laying down Union procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency (Text with EEA relevance)Text with EEA relevance
• Regulation (EC) No 1610/96 of the European Parliament and of the Council of 23 July 1996 concerning the creation of a supplementary protection certificate for plant protection products
• Directive 2011/62/EU of the European Parliament and of the Council of 8 June 2011 amending Directive 2001/83/EC on the Community code relating to medicinal products for human use, as regards the prevention of the entry into the legal supply chain of falsified medicinal products Text with EEA relevance
• Directive 2001/82/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to veterinary medicinal products
• Treaty establishing the European Community